Indeed, even though CD276 displays a widespread expression pattern in mouse and human tissues, the fact that it is so highly expressed by tumour cells and the associated tumour vasculature, resulted in ADCs against CD276 only having substantial effects upon the tumour microenvironment. This evidence concerns the gene CD276 and neoplasm.